Postoperative induction of insulin-like growth factor binding protein-3 proteolytic activity: Relation to insulin and insulin sensitivity

Journal of Clinical Endocrinology and Metabolism

Volumn 83, Issue 7, 1998, Pages 2509-2515

  Bang, Peter ^a,b   Nygren, Jonas ^a   Carlsson Skwirut, Christine ^a   Thorell, Anders ^a   Ljungqvist, Olle ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; GLUCOSE; INSULIN; MATRIX METALLOPROTEINASE; NEUTRAL INSULIN; SERINE PROTEINASE; SOMATOMEDIN; SOMATOMEDIN BINDING PROTEIN 3;

ADULT; ARTICLE; BIOAVAILABILITY; CLINICAL ARTICLE; COLORECTAL SURGERY; DOSE TIME EFFECT RELATION; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; HUMAN; IMMUNOBLOTTING; INSULIN INFUSION; INSULIN RESISTANCE; INSULIN SENSITIVITY; ORAL GLUCOSE TOLERANCE TEST; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION; PROTEIN EXPRESSION;

ADMINISTRATION, ORAL; ADULT; BIOLOGICAL AVAILABILITY; BLOTTING, WESTERN; ENDOPEPTIDASES; FASTING; GLUCOSE; GLUCOSE CLAMP TECHNIQUE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN RESISTANCE; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; MIDDLE AGED; POSTOPERATIVE PERIOD;

EID: 0031728428     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.83.7.2509     Document Type: Article

References (37)

1. Jones JI, Clemmons DR. 1995 Insulin-like growth factors and their binding proteins. Endocr Rev. 16:3-34.
2. Bar RS, Boes M, Dake BL, et al. 1990 Tissue localization of perfused endothelial cell IGF binding protein is markedly altered by association with IGF-I. Endocrinology. 127:3243-3245.
3. Binoux M, Lalou C, Lassarre C, Blat C, Hossenloop P. 1994 Limited proteolysis of insulin-like growth factor binding rotein-3 (IGFBP-3): a physiological mechanism in the regulation of IGF biavailability. In: LeRoith D, Raizada MK, eds. Current directions in insulin-like growth factor research. New York: Plenum Press; 293-300.
4. Bang P. 1995 Serum proteolysis of IGFBP-3. Prog Growth Factor Res 6:285-292.
5. Conover CA. 1995 Insulin-like growth factor binding protein proteolysis in bone cell models. Prog Growth Factor Res 6:301-309.
6. Angelloz-Nicoud P, Binoux M. 1995 Autocrine regulation of cell proliferation by the insulin-like growth factor (IGF) and IGF binding protein-3 protease system in a human prostate carcinoma cell line (PC-3). Endocrinology. 136:5485-5492.
7. Lassarre C, Binoux M. 1994 Insulin-like growth factor binding protein-3 is functionally altered in pregnancy plasma. Endocrinology. 134:1254-1262.
8. Blat C, Villaudy J, Binoux M. 1994 In vivo proteolysis of serum insulin-like growth factor (IGF) binding protein-3 results in increased availability of IGF to target cells. J Clin Invest. 93:2226-2229.
9. Giudice LC, Farrell EM, Pham H, Lamson G, Rosenfeld RG. 1990 Insulin-like growth factor binding proteins in maternal serum throughout gestation and in the puerperium: effects of a pregnancy-associated serum protease activity. J Clin Endocrinol Metab. 71:806-816.
10. Hossenlopp P, Sergovia B, Lassarre C, Roghani M, Bredon M, Binoux M. 1990 Evidence of enzymatic degradation of insulin-like growth factor-binding proteins in the 150K complex during pregnancy. J Clin Endocrinol Metab. 71:797-805.
11. Baxter RC, Martin JL, Beniac VA. 1989 High molecular weight insulin-like growth factor complex; purification and properties of the acid-labile subunit from human serum. J Biol Chem. 264:11843-11848.
12. Bang P. 1994 Insulin-like growth factor (IGF)-I, and IGF binding proteins: serum concentrations, bioavailability and effects of proteases. PhD Thesis. Stockholm: Karolinska Institute; ISBN-91-628-1327-7.
13. Lee GY, Rechler MM. 1996 Proteolysis of insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) in 150-kilodalton IGFBP complexes by a cation-dependent protease activity in adult rat serum promotes the release of bound IGF-I. Endocrinology. 137:2051-2058.
14. Bang P, Fielder JP. 1998 Human pregnancy serum contains at least two distinct proteolytic activities with the ability to degrade insulin-like growth factor 3. Endocrinology. 138: 3912-3917.
15. Frystyk J, Skjaerbaek C, Dinesen B, Orskov H. 1994 Free insulin-like growth factors (IGF-I and IGF-II) in human serum. FEBS Lett. 348:185-191.
16. Davies SC, Wass JA, Ross RJ, et al. 1991 The induction of a specific protease for insulin-like growth factor binding protein-3 in the circulation during severe illness. J Endocrinol. 130:469-473.
17. Davenport MS, Isley WL, Pucilowska JB, et al. 1992 Insulin-like growth factor-binding protein-3 proteolysis is induced after elective surgery. J Clin Endocrinol Metab 75:590-595.
18. Cwyfan Hughes SC, Cotterill AM, Molloy AR, et al. 1992 The induction of specific proteases for insulin-like growth factor-binding proteins following major heart surgery. J Endocrinol. 135:135-145.
19. Cotterill AM, Mendel P, Holly JM, et al. 1996 The differential regulation of the circulating levels of the insulin-like growth factors and their binding proteins (IGFBP) 1, 2 and 3 after elective abdominal. Clin Endocrinol. 44:91-101.
20. Timmins AC, Cotterill AM, Hughes SC, et al. 1996 Critical illness is associated with low circulating concentrations of insulin-like growth factors-I and -II, alterations in insulin-like growth factor binding proteins, and induction of an insulin-like growth factor binding protein 3 protease. Crit Care Med. 24:1460-1466.
21. Bang P, Brismar K, Rosenfeld RG. 1994 Increased proteolysis of insulin-like growth factor binding protein-3 (IGFBP-3) in non insulin-dependent diabetes mellitus serum, with elevation of a 29 kDa glycosylated IGFBP-3 fragment contained in the approximately 130- to 150-kDa ternary complex. J Clin Endocrinol Metab. 78:1119-1127.
22. Nygren J, Soop M, Thorell A, Efendic S, Nair KS, Ljungqvist O. 1998 Preoperative oral carbohydrate administration reduces postoperative insulin resistance. Clin Nutr. 17: 65-71.
23. Nygren J, Thorell A, Efendic S, Nair KS, Ljungqvist. 1997 Site of insulin resistance after surgery: the contribution of hypocaloric nutrition and bed rest. Clin Sci. 93:137-146.
24. Nygren J, Thorell A, Jacobsson H, et al. 1995 Preoperative gastric emptying. Effects of anxiety and oral carbohydrate administration. Ann Surg. 222:728-734.
25. Grill V, Pigeon J, Hartling S, Binder C, Efendic S. 1990 Effects of dexamethasone on glucose-induced insulin and proinsulin release in low and high responders. Metabolism. 39:251-258.
26. Lamson G, Giudice LC, Rosenfel RG. 1991 A simple assay for proteolysis of IGFBP-3. J Clin Endocrinol Metab. 72:1391-1393.
27. Hossenlopp P, Seurin D, Segovia-Quinson B, Hardouin S, Binoux M. 1986 Analysis of serum insulin-like growth factor binding proteins using western blotting: use of the method for titration of the binding proteins and competitive binding studies. Anal Biochem. 154:138-143.
28. Suikkari AM, Baxter RC. 1991 Insulin-like growth factor (IGF) binding protein-3 in pregnancy serum binds native IGF-I but not iodo-IGF-I. J Clin Endocrinol Metab. 73:1377-1379.
29. Dohm GL, Elton CW, Raju MS, et al. 1990 IGF-I-stimulated glucose transport in human skeletal muscle, and IGF-I resistance in obesity and NIDDM. Diabetes. 39:1028-1032.
30. Zierath JR, Bang P, Galuska D, Hall K, Wallberg-Henriksson. 1992 Insulin-like growth factor II stimulates glucose transport in human skeletal muscle. FEBS Lett. 307:379-382.
31. Redmond HP, Watson RW, Houghton T, Condron C, Watson RG, Bouchier-Hayes D. 1994 Immune function in patients undergoing open vs laparoscopic cholecystectomy. Arch Surg. 129:1240-1246.
32. Tang GJ, Kuo CD, Yen TC, et al. 1996 Perioperarive plasma concentrations of tumor necrosis factor-α and interleukin-6 in infected patients. Crit Care Med. 24:423-428.
33. Hotamisligil GS, Peraldi P, Budavari A, Ellis R, White MF, Spiegelman BM. 1996 IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance. Science. 271:665-668.
34. Skolnik EY, Marcusohn J. 1996 Inhibition of insulin receptor signaling by TNF: potential role in obesity and non-insulin-dependent diabetes mellitus. Cytokine Growth Factor Rev. 7:161-173.
35. Hanemaaijer R, Koolwijk P, le Clercq L, de Vree WJ, van Hinsbergh VW. 1993 Regulation of matrix metalloproteinase expression in human vein and microvascular endothelial cells. Effects of tumour necrosis factor alpha, interleukin 1 and phorbol ester. Biochem J. 296:803-809.
36. Galis ZS, Muszynski M, Sukhova GK, Simon-Morrissey E, Libby P. 1995 Enhanced expression of vascular matrix metalloproteinases induced in vitro by cytokines and in regions of human atherosclerotic lesions. Ann NY Acad Sci. 748:501-507.
37. Rajah R, Bhala A, Nunn SE, Peehl DM, Cohen P. 1996 7S nerve growth factor is an insulin-like growth factor-binding protein protease. Endocrinology. 137: 2676-2682.